The global ProteomicsMarketwas valued at USD 12.54 billion in 2016 and is projected to reach USD 33.88 billion by 2025, growing at a CAGR of 11.68% from 2017 to 2025.
Proteomics is a branch of biotechnology which involves protein assays and analysis. Due to increasing demand of pharmaceutical product and services, coupled with diagnostic services, the market is expected to grow during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Demand for Personalized Medicine
1.2 Proteomics Bridges the Gap Between Genome Sequence and Cellular Behavior
1.3 Increasing Pharmaceutical and Biotech R&D Expenditure
1.4 Technological Advancements
1.5 Availability of Government and Private Funding
2. Market Restraints
2.1 Sequestration Cuts in the U.S. and Reduced Funds for Proteomic Research
2.2 Huge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities
2.3 Expensive Tools and Instruments and Their Maintenance
Market Segmentation:
1. Global Proteomics Market, by Application:
1.1 Drug Discovery
1.2 Clinical Diagnostics
1.3 Other Proteomics Applications
2. Global Proteomics Market, by Services and software:
2.1 Analytical Laboratory Services
2.1.1 Protein Identification
2.1.2 Protein Separation
2.1.3 Protein Sequencing
2.2 Data Analysis & Maintenance
2.2.1 Bioinformatics Databases
2.2.2 Bioinformatics Tools
2.3 Quantitation Services
3. Global Proteomics Market, by Reagent:
3.1 Protein Microarray Reagents
3.2 Spectroscopy Reagents
3.3 X-Ray Crystallography Reagents
3.4 Chromatography Reagents
3.5 Electrophoresis Reagents
3.6 Immunoassay Reagents
3.7 Protein Fractionation Reagents
4. Global Proteomics Market, by Instrumentation Technology:
4.1 Protein Microarrays
4.1.1 Biochips
4.1.2 Microarray Instruments
4.2 Spectroscopy
4.2.1 Mass Spectroscopy
4.2.2 NMR Spectroscopy
4.2.3 CD Spectroscopy
4.3 X-Ray Crystallography
4.4 Chromatography
4.4.1 HPLC
4.4.2 Ion Chromatography
4.4.3 Affinity Chromatography
4.4.4 Supercritical Fluid Chromatography
4.5 Electrophoresis
4.5.1 Gel Electrophoresis
4.5.2 Capillary Electrophoresis
4.6 Surface Plasmon Resonance (SPR)
4.7 Protein Fractionation
5. Global Proteomics Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific, Inc.
2. Agilent Technologies, Inc.
3. Bio-Rad Laboratories, Inc.
4. Merck KGaA
5. Danaher Corporation
6. Luminex Corporation
7. Perkinelmer, Inc.
8. Waters Corporation
9. GE Healthcare
10. Bruker Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the ProteomicsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL PROTEOMICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL PROTEOMICSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL PROTEOMICS MARKET, BY APPLICATION
5.1 Drug Discovery
5.2 Clinical Diagnostics
5.3 Other Proteomics Applications
6 GLOBAL PROTEOMICS MARKET, BY SERVICES AND SOFTWARE
6.1 Analytical Laboratory Services
6.1.1 Protein Identification
6.1.2 Protein Separation
6.1.3 Protein Sequencing
6.2 Data Analysis & Maintenance
6.2.1 Bioinformatics Databases
6.2.2 Bioinformatics Tools
6.3 Quantitation Services
7 GLOBAL PROTEOMICS MARKET, BY REAGENT
7.1 Protein Microarray Reagents
7.2 Spectroscopy Reagents
7.3 X-Ray Crystallography Reagents
7.4 Chromatography Reagents
7.5 Electrophoresis Reagents
7.6 Immunoassay Reagents
7.7 Protein Fractionation Reagents
8 GLOBAL PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY
8.1 Protein Microarrays
8.1.1 Biochips
8.1.2 Microarray Instruments
8.2 Spectroscopy
8.2.1 Mass Spectroscopy
8.2.2 NMR Spectroscopy
8.2.3 CD Spectroscopy
8.3 X-Ray Crystallography
8.4 Chromatography
8.4.1 HPLC
8.4.2 Ion Chromatography
8.4.3 Affinity Chromatography
8.4.4 Supercritical Fluid Chromatography
8.5 Electrophoresis
8.5.1 Gel Electrophoresis
8.5.2 Capillary Electrophoresis
8.6 Surface Plasmon Resonance (SPR)
8.7 Protein Fractionation
9 GLOBAL PROTEOMICSMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL PROTEOMICSMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Agilent Technologies, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Merck KGaA
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Danaher Corporation
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Luminex Corporation
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Perkinelmer, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Waters Corporation
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 GE Healthcare
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Bruker Corporation
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports